within Pharmacolibrary.Drugs.ATC.G;

model G03AC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.19 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.75 / 1000000,
    adminCount     = 1,
    Vd             = 0.0018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 420.0
  );

  annotation(Documentation(
    info ="<html><body><p>Levonorgestrel is a synthetic progestogen used primarily as an emergency contraceptive and as an active component in various hormonal contraceptive regimens, including oral contraceptives, intrauterine devices (IUDs), and subdermal implants. It is approved by regulatory agencies such as the FDA and is widely used today for both prevention of pregnancy after unprotected intercourse and for long-term contraception.</p><h4>Pharmacokinetics</h4><p>Healthy adult women, single oral dose, fasting state.</p><h4>References</h4><ol><li><p>Leelakanok, N, &amp; Methaneethorn, J (2020). A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive. <i>Clinical drug investigation</i> 40(5) 395–420. DOI:<a href=&quot;https://doi.org/10.1007/s40261-020-00901-x&quot;>10.1007/s40261-020-00901-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32162237/&quot;>https://pubmed.ncbi.nlm.nih.gov/32162237</a></p></li><li><p>Ginstman, C, et al., &amp; Brynhildsen, J (2020). Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls. <i>Obesity surgery</i> 30(6) 2217–2224. DOI:<a href=&quot;https://doi.org/10.1007/s11695-020-04447-x&quot;>10.1007/s11695-020-04447-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32030619/&quot;>https://pubmed.ncbi.nlm.nih.gov/32030619</a></p></li><li><p>Moreira de Brito, C, et al., &amp; Cercato, C (2021). Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery. <i>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</i> 17(4) 673–681. DOI:<a href=&quot;https://doi.org/10.1016/j.soard.2020.12.007&quot;>10.1016/j.soard.2020.12.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33547015/&quot;>https://pubmed.ncbi.nlm.nih.gov/33547015</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03AC03;
